Skip to content

Nitrous Oxide for Lumbar Puncture

Impact of 50% Nitrous Oxide Inhalation on Pain and Anxiety Induced by Lumbar Puncture: a Multicenter Double-blind Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03228628
Acronym
NO for LP
Enrollment
162
Registered
2017-07-25
Start date
2017-10-01
Completion date
2019-09-01
Last updated
2017-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain

Keywords

Spinal puncture, Pain, Anxiety, Nitrous oxyde

Brief summary

Lumbar puncture (LP) is a frequent exam that can cause pain and anxiety. In a pilot single-center study, it has been shown that nitrous oxide use during the procedure was able to reduce both pain and anxiety (Moisset et al., Eur J Neurol 2017). The goal of this multi-center trial is to confirm these results in a larger and more heterogeneous group of patients having a LP.

Detailed description

Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a century. Nonetheless, it's use during lumbar puncture in adults has only been investigated in a single-centre study. Thus, this study is designed to evaluate the analgesic effect of N2O on the pain induced during lumbar puncture. Patients with scheduled lumbar puncture realized for diagnosis purposes will be randomized in 2 groups. One group will inhale N2O for the 5 minutes before the puncture and during the rest of the procedure. The second group will inhale compressed air during the same period of time. Neither the investigator realizing the lumbar puncture, nor the patient will know which type of gaz they are inhaling (double-blinding). The maximal pain level that occurred during the procedure will be evaluated on a Numerical Rating Scale (NRS). NRS will also be used to evaluate the maximal anxiety induced by the procedure.

Interventions

Gaz inhalation will start 5 minutes before the puncture and will be continued until the end of the procedure.

OTHERPlacebo

inhale medical air (22% O2 - 78% N2)

Sponsors

University Hospital, Bordeaux
CollaboratorOTHER
Hospices Civils de Lyon
CollaboratorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
Université d'Auvergne
CollaboratorOTHER
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

double blinding. Gaz bottles are in undistinguishable boxes. Neither the patients nor the person doing the LP and the evaluation of pain and anxiety will know the treatment used

Intervention model description

1:1 randomization to receive experimental treatment (50% N2O - 50% O2) or placebo (Medical Air: 22% O2 - 78% N2)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients coming in the neurology department for a lumbar puncture * at least 18 * no previous use of nitrous oxide

Exclusion criteria

* contra-indication to nitrous oxide use * Body Mass Index\>35 * Mini Mental State Examination \<24/30 * Temperature \>38°C * Confusion * Patient unable to communicate verbaly

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients with significant pain2-3 minutes after the end of gaz inhalationmaximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale

Secondary

MeasureTime frameDescription
Analgesic efficacy measured with pain as a continuous variable2-3 minutes after the end of gaz inhalation.maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale
Anxiolytic efficacy measured with anxiety as a continuous variable2-3 minutes after the end of gaz inhalationmaximal anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Pain during the procedure evaluated one hour after the end of the lumbar puncture1 hour after the end of gaz inhalationmaximal pain and anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Proportion of patients with significant anxiety2-3 minutes after the end of gaz inhalationmaximal anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Side effectsfrom the beginning of gaz inhalation to 24 hours laterevery side effects reported by the patients during the procedure up to 24 hours after the lumbar puncture, including post-puncture puncture headache
Impact of age on side effectsduring the procedure and the 24 hours afterincidence and type of side effects according to patient age
Induced costat day 1supplementary cost induced by the use of nitrous oxide inhalation for a total of 81 patients throughout the study
Anxiety during the procedure evaluated one hour after the end of the lumbar puncture1 hour after the end of gaz inhalationmaximal pain and anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026